M&A Negotiation

  • Thursday June 27th, 9:20 AM – 10:20 AM

    This session will discuss the seven key drivers of value in a medtech company and how they impact merger negotiations. Attendees will get an overview of factors that acquirers consider in M&A transactions and have an opportunity to ask questions to one of the leading medtech bankers and investors.

    As it becomes more and more difficult to raise significant funding to advance therapeutics, many companies have adopted M&A as a more feasible exit strategy than reaching commercialization. This has only gotten stronger with the emergence of big pharma as a leading player in venture and early stage funding. On the other side, successful companies are embracing new valuation models from investors centered on multiple pipelines and tangible short-term revenue. In a moribund sector, however, companies on both sides of the table must tread softly as to avoid terms that may promise long-term promise, but short-term demise. This workshop will explore the intricacies in reaching M&A compromise, specifically:

    • Placating aggressive suitors
    • Balancing short-term satisfaction with long-term loyalty
    • Mollifying early-round investors
    • Proper acquisition valuation before and after commercialization
    • Diversifying a pipeline and portfolio
    • Licensing and strategic partnership vs. M&A

     

    Hosted by MedCap Advisors

     

    Faculty:

    Chris_Velis.M&AChris Velis, CEO and Chairman, MedCap Advisors, has 20 years of experience leading transformative transactions, affecting the global healthcare markets. Chris provides M&A guidance and consulting to the top ventures in the healthcare and medical technology industry.

     

     

     

     

  • Conference Info:

     

    Date: June 26-27, 2013
    Location: The Metropolitan Club, New York City


    Audience: Institutional investors, high net worth individual investors, family offices, business development executives throughout the US and Europe building and financing high growth medical technology, health care and life science companies.

    View the Schedule!

    View the Agenda!